Natera (NTRA) Cash from Financing Activities (2014 - 2026)
Natera's (NTRA) quarterly Cash from Financing Activities came in at $12.2 million in Q2 2026, down 2.94% on a YoY basis from $12.6 million in Q2 2025, and up 224.8% quarter-over-quarter from $3.8 million in Q1 2026.
Analysis
Natera (NTRA) Cash from Financing Activities (2014 - 2026) Analysis & Trends
Natera (NTRA) has reported Cash from Financing Activities for 13 consecutive years, with $12.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Financing Activities fell 2.94% year-over-year to $12.2 million; the trailing twelve-month figure through Jun 2026 stood at $50.3 million (up 94.87% YoY), and the FY2025 full-year result was $47.5 million, up 57.13% from the prior year.
- Cash from Financing Activities rose to $12.2 million in Q2 2026 per NTRA's latest filing, from $3.8 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $468.2 million in Q4 2022 and bottomed at $544000.0 in Q1 2025.
- Historically, Cash from Financing Activities has averaged $46.2 million across 5 years, with a median of $7.9 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities plunged 99.75% in 2022, then soared 16842.07% in 2023.
- Over 5 years, Cash from Financing Activities stood at $468.2 million in 2022, then sank by 98.54% to $6.8 million in 2023, then jumped by 60.32% to $11.0 million in 2024, then jumped by 195.3% to $32.4 million in 2025, then plunged by 62.33% to $12.2 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered $12.2 million, $3.8 million, and $32.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | 12.21 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | -229.00 Mn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | -919.90 Mn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | 23.01 Mn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | 97.12 Mn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | -36.90 Mn |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | -2.41 Mn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 6.09 Mn |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | 142.19 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | 4.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.21 Mn |
| Mar 31, 2026 | 3.76 Mn |
| Dec 31, 2025 | 32.41 Mn |
| Sep 30, 2025 | 1.94 Mn |
| Jun 30, 2025 | 12.58 Mn |
| Mar 31, 2025 | 544,000.00 |
| Dec 31, 2024 | 10.97 Mn |
| Sep 30, 2024 | 1.72 Mn |
| Jun 30, 2024 | 11.04 Mn |
| Mar 31, 2024 | 6.47 Mn |
| Dec 31, 2023 | 6.85 Mn |
| Sep 30, 2023 | 236.00 Mn |
| Jun 30, 2023 | 9.31 Mn |
| Mar 31, 2023 | 2.30 Mn |
| Dec 31, 2022 | 468.17 Mn |
| Sep 30, 2022 | 1.39 Mn |
| Jun 30, 2022 | 8.92 Mn |
| Mar 31, 2022 | 4.16 Mn |
| Dec 31, 2021 | 8.52 Mn |
| Sep 30, 2021 | 554.76 Mn |